Business Context and Reporting Period
Company: Intelligent Bio Solutions Inc. (INBS)
Filing Type: Form 8-K (Current Report)
Date of Report: February 2, 2024
Reporting Period: Three months ended December 31, 2023 (Q4 2023)
Context: The Company issued a press release announcing preliminary unaudited revenue results for the quarter. The Company is an emerging growth company.
Key Financial Metrics
The filing text references the announcement of preliminary unaudited revenue results for the three months ended December 31, 2023, but does not explicitly state the specific revenue figure, profit, cash flow, margins, debt, or liquidity metrics within the body of this 8-K document. These details are contained in the attached Exhibit 99.1 (Press Release), which is not included in the provided text.
Material Changes
The filing does not provide specific comparative data or material changes versus the prior comparable period. It solely serves as a notification that preliminary results have been issued.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the issuance of a press release regarding Q4 2023 revenue but contains no further management commentary, guidance, or outlook in the text provided.
Risks and Contingencies: No specific risks or contingencies are detailed in this filing text.
Unusual Items: None reported in the text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for the specific preliminary revenue figure for the three months ended December 31, 2023.
- Verify the unaudited nature of the reported results and compare them against prior year guidance or actuals once the full press release is accessed.
- Confirm the Company's status as an emerging growth company and any implications for financial reporting standards.
- Check subsequent filings (e.g., 10-Q) for the audited or finalized version of these results.